Abramson Cancer Center
Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Registration Number
- NCT00002902
- Locations
- 🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2004-03-26
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT00002592
- Locations
- 🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-03-10
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 28
- Registration Number
- NCT00079157
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
MRI to Detect Breast Tumors in Women
- Conditions
- Breast Cancer
- First Posted Date
- 2004-03-01
- Last Posted Date
- 2019-09-25
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 1500
- Registration Number
- NCT00003302
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸Cancer Center at the University of Virginia, Charlottesville, Virginia, United States
Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2004-02-12
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT00077519
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2003-12-10
- Last Posted Date
- 2022-01-26
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 35
- Registration Number
- NCT00003777
- Locations
- 🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2003-08-20
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 200
- Registration Number
- NCT00003736
- Locations
- 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States
🇺🇸Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
- Conditions
- Cancer
- First Posted Date
- 2003-08-07
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Registration Number
- NCT00066404
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT00025480
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States